Valuation: Vext Science, Inc.

Market Cap 4.54Cr 3.99Cr 3.67Cr 3.43Cr 6.44Cr 428.16Cr 6.56Cr 44Cr 17Cr 211.06Cr 17Cr 17Cr 733.46Cr P/E 2026 *
-18.6x
P/E 2027 * 18.6x
Enterprise Value 3.15Cr 2.76Cr 2.55Cr 2.38Cr 4.47Cr 297Cr 4.55Cr 31Cr 12Cr 146.4Cr 12Cr 12Cr 508.77Cr EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.66x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 week+4.00%
1 month-3.70%
3 months+15.56%
6 months-7.14%
Current year+1.96%
1 week 0.26
Extreme 0.255
0.26
1 month 0.24
Extreme 0.24
0.28
Current year 0.22
Extreme 0.22
0.4
1 year 0.15
Extreme 0.15
0.4
3 years 0.1
Extreme 0.1
0.42
5 years 0.1
Extreme 0.1
0.92
10 years 0.1
Extreme 0.1
2.1
Manager TitleAgeSince
Chief Executive Officer - 18/02/2020
Director of Finance/CFO - 25/08/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 45 11/12/2015
Director/Board Member - 14/02/2020
Chairman 69 20/08/2024
Date Insider Type Main position Quantity % Market Cap.
05/01Sell

Director

13,34,000 0.8075%
05/01Other

Director

0 0%
05/01Sell

Founder

20,340 2.9973%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.00%+92.59%0.00% 4.54Cr
0.00%-3.66%+77.78%+209.82% 21Cr
+0.74%-1.45%-24.86%-33.98% 13Cr
+3.23%0.00%+15.94%+88.24% 11Cr
0.00%-13.46%+55.17%-27.42% 9.13Cr
+9.20%+0.12%+55.08%-7.58% 9.6Cr
-4.10%+10.07%-42.17%-55.27% 5.57Cr
Average +1.30%-0.62%+32.79%+24.83% 10.64Cr
Weighted average by Cap. +1.50%-1.93%+36.18%+57.79%

Financials

2026 *2027 *
Net sales 5.38Cr 4.73Cr 4.35Cr 4.07Cr 7.64Cr 507.66Cr 7.78Cr 52Cr 20Cr 250.25Cr 20Cr 20Cr 869.66Cr 6.89Cr 6.06Cr 5.58Cr 5.22Cr 9.79Cr 650.58Cr 9.96Cr 67Cr 26Cr 320.7Cr 26Cr 25Cr 1.11TCr
Net income -23L -20.2L -18.61L -17.4L -32.64L -22Cr -33.24L -2.23Cr -86.51L -11Cr -86.37L -84.48L -37Cr 23.7L 20.82L 19.18L 17.94L 33.64L 22Cr 34.26L 2.3Cr 89.16L 11Cr 89.02L 87.07L 38Cr
Net Debt -1.39Cr -1.22Cr -1.12Cr -1.05Cr -1.97Cr -131.16Cr -2.01Cr -13Cr -5.23Cr -65Cr -5.22Cr -5.11Cr -224.69Cr 1L 87.84T 80.93T 75.67T 1L 94.36L 1L 10L 4L 46.51L 4L 4L 1.62Cr
Logo Vext Science, Inc.
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Employees
-
Date Price Change Volume
25/26/25 CA$0.2600 +1.96% 13,500
24/26/24 CA$0.2550 +2.00% 5,500
18/26/18 CA$0.2500 -3.85% 39,103
17/26/17 CA$0.2600 +6.12% 5,000
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2600CAD
Average target price
0.9500CAD
Spread / Average Target
+265.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VEXT Stock